Get the Stockscreener App
176.66
2.38%
-4.30
After Hours:
177.00
0.34
+0.19%
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $176.66, with a volume of 3.32M.
It is down -2.38% in the last 24 hours and down -13.16% over the past month.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.
See More
Previous Close:
$180.96
Open:
$181.84
24h Volume:
3.32M
Relative Volume:
1.52
Market Cap:
$50.25B
Revenue:
$21.92B
Net Income/Loss:
$1.76B
P/E Ratio:
28.86
EPS:
6.1223
Net Cash Flow:
$2.63B
1W Performance:
-3.18%
1M Performance:
-13.16%
6M Performance:
-8.97%
1Y Performance:
-22.38%
1-Day Range:
$175.92
$182.27
1-Week Range:
$175.92
$187.35
52-Week Range:
$162.29
$235.34
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
176.66 | 51.48B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ISRG
Intuitive Surgical Inc
|
506.88 | 179.76B | 10.06B | 2.88B | 2.49B | 7.876 |
|
ALC
Alcon Inc
|
86.72 | 42.38B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
48.89 | 39.09B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
257.06 | 36.79B | 5.40B | 1.49B | 1.78B | 10.12 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-26 | Resumed | Barclays | Overweight |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Sep-25-25 | Initiated | RBC Capital Mkts | Sector Perform |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
Becton, Dickinson and Company (BDX) Announces Early Tender Resul - GuruFocus
Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase - Becton Dickinson
Becton Dickinson Expands Debt Tender Offers Amid Strong Demand - TipRanks
Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap - Becton Dickinson
Point of Care Diagnostics Market Competitive Landscape - GlobeNewswire
Point of Care Diagnostics Market Competitive Landscape Report 2025 Featuring Top 5 PlayersSysmex, Abbott Laboratories, Becton Dickinson and Co, Danaher, Quidel Diagnostics - Yahoo Finance Singapore
Becton Dickinson hires Walgreens Boots Alliance CLO as next legal head - The Global Legal Post
Becton, Dickinson and Company (BDX) Stock Analysis: Assessing Growth Potential with a 5.39% Upside - DirectorsTalk Interviews
BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency - Finviz
New BD urine test kit aims to cut repeat samples, reduce contamination - Stock Titan
Becton Dickinson Sharpens Focus Through Strategic Financial Moves - AD HOC NEWS
Tredje AP fonden Grows Stake in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson stock hits 52-week high at 185.0 USD By Investing.com - Investing.com India
Becton, Dickinson and Company (NYSE:BDX) Reaches New 12-Month HighHere's What Happened - MarketBeat
Former Walgreens Legal Chief Joins Medical Device Giant Becton Dickinson - Law.com
Becton Dickinson stock hits 52-week high at 185.0 USD - Investing.com
Lanesha Minnix Named General Counsel for BD - citybiz
Walgreens deal veteran Lanesha Minnix to lead BD legal and public affairs - Stock Titan
First National Bank of Omaha Acquires New Holdings in Becton, Dickinson and Company $BDX - MarketBeat
BD CEO says 'lean manufacturing'—Toyota's famous philosophy—is prerequisite for leveraging AI - Fortune
Becton, Dickinson and Company $BDX Shares Sold by HighTower Advisors LLC - MarketBeat
Insider Sell: Bertram Scott Sells Shares of Becton Dickinson & C - GuruFocus
Becton, Dickinson and Company (NYSE:BDX) Director Sells 953 Shares - MarketBeat
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Reassessing Becton Dickinson (BDX) After Recent Share Price Volatility - Yahoo Finance
First Pacific Advisors' Strategic Moves: Spotlight on Becton Dic - GuruFocus
First Pacific Advisors' Strategic Moves: Spotlight on Becton Dickinson & Co - Yahoo Finance
Fund Update: 1,014,989 BECTON, DICKINSON (BDX) shares added to First Pacific Advisors, LP portfolio - Quiver Quantitative
Hemostasis Products Market Size to Reach USD 3.28 Billion by 2035 with 5.41% CAGR – SNS Insider - GlobeNewswire Inc.
Vanguard Group Inc. Increases Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
Heartland Advisors Inc. Purchases 16,805 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Glenview Trust Co Has $11.04 Million Stake in Becton, Dickinson and Company $BDX - MarketBeat
5 Must-Read Analyst Questions From BD's Q4 Earnings Call - Finviz
Becton, Dickinson and Company (BDX) Stock Analysis: Exploring the 11.08% Potential Upside for Investors - DirectorsTalk Interviews
Becton, Dickinson and Company’s Bilal Muhsin on the future of Connected Care - Gulf Business
Will Becton Dickinson and Company stock see insider buyingIPO Watch & Precise Swing Trade Entry Alerts - mfd.ru
Assetmark Inc. Increases Holdings in Becton, Dickinson and Company $BDX - Defense World
Cibc World Market Inc. Has $8.25 Million Stake in Becton, Dickinson and Company $BDX - MarketBeat
Citi Raises Becton Dickinson (BDX) PT to $198 after Life Sciences Sale Update - Finviz
Becton Dickinson Resets Core Focus With Spin Off And $2b Buyback - Yahoo Finance
Becton, Dickinson and Company (NYSE:BDX) Downgraded by Zacks Research to Strong Sell - MarketBeat
Becton, Dickinson and Company $BDX Shares Sold by Rhumbline Advisers - MarketBeat
Krilogy Financial LLC Takes Position in Becton, Dickinson and Company $BDX - MarketBeat
Assessing Becton Dickinson (BDX) Valuation After Recent Share Price Weakness - simplywall.st
TD Cowen Raises Becton, Dickinson and Company (NYSE:BDX) Price Target to $189.00 - MarketBeat
Becton, Dickinson and Company (NYSE:BDX) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Candriam S.C.A. Has $2.87 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
ABC Arbitrage SA Takes Position in Becton, Dickinson and Company $BDX - MarketBeat
BD Merges Biosciences & Diagnostics Business With Waters - Yahoo Finance
Becton Dickinson & Co (BDX) Shares Up 3.75% on Feb 11 - GuruFocus
Becton Dickinson (BDX): Citigroup Maintains Rating but Lowers Pr - GuruFocus
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):